Navigation Links
Medivir Interim Report, 1 January - 30 September 2010
Date:10/22/2010

commercial value of our innovative cold sore product Xerclear(R)/Xerese(R ) and have signed two further agreements in different geographic markets.

The success demonstrated with Xerclear(R) and Xerese(R) shows Medivir's ability to develop and commercialize products and collaborate with blue-chip partners.

Following the successful rights issue concluded in June 2010 we are in healthy financial position and have therefore been able to remain focused on developing our exciting portfolio of early-phase projects for infectious diseases.

Medivir is positioned uniquely among specialty pharmaceutical companies with a potential blockbuster Hepatitis C therapy in late-stage development, a marketed product, Xerclear(R)/Xerese(R), approaching international launch, a broad earlier pipeline and a solid financial position. Medivir will now remain focused on creating further shareholder value and continues to gain momentum in its strategic goal to become a profitable specialty pharmaceutical company. We look forward to sharing our exciting future news flow going forward with both our patients and our shareholders as we continue to build the growth in this business."

For the full Q3 report please visit http://www.medivir.se. For more information, please contact Rein Piir, CFO and VP, Investor Relations, mobile: +46(0)70-853-7292. Ron Long, CEO, phone: +46(0)8-5468-3113. Forthcoming financial information and calendar Financial Statement will be published on 22 February 2011. Three-month Interim Report will be published on 5 May 2011. Annual General Meeting will be held on 5 May 2011.

Additional information on Medivir's operations is available on the company's website, http://www.medivir.se.


'/>"/>
SOURCE Medivir AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Impact of Healthcare Reform ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient ... complex legislation that affects virtually every aspect of ... beginning to take effect now. IVD manufacturers who ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Personal Accident and ... Opportunities to 2018 ... provides in depth market analysis, information and ... health insurance segment, including: - The French ...
Breaking Medicine Technology:The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
... 28 Danaher Corporation (NYSE: DHR ) announced ... Comas will be presenting at the Goldman Sachs Global Industrials ... at 10:15 a.m. EDT. The company also announced that President ... presenting at the Robert W. Baird Industrial Conference in Chicago, ...
... The U.S. Food and Drug Administration today ... of adults with schizophrenia. (Logo: ... ) Schizophrenia affects about 1 ... and older, in a given year. The most ...
Cached Medicine Technology:FDA Approves Latuda to Treat Schizophrenia in Adults 2
(Date:8/20/2014)... both breast cancer relapses and responses to chemotherapy, ... newly found marker could help doctors classify each ... that is more effective. The discovery was a ... Molecular and Cell Biology (IMCB), and the Cancer ... National University of Singapore (NUS). , Despite advancements ...
(Date:8/20/2014)... 20, 2014 It’s no secret that ... to the National Institute on Drug Abuse, nearly 24 ... What’s even more alarming is the fact that the ... decade. , Those locked in a struggle with substance ... out. But now, the newly-redesigned AbuseTreatmentCenters.net has released updated ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Little Green ... Really Little Green Pouch —to meet growing demand ... babies and toddlers homemade foods. , “The Real ... Pouch co-founder Maggie Crawford. She continues, “Parents want ... limit exposure to things like pesticides and hidden ingredients ...
(Date:8/20/2014)... Botanica Day Spa ... the new and popular stem cell line from ... and wrinkles and naturally repairs the skin. The ... new service by offering clients a complimentary dermaplaning ... facial. , Pevonia® continues to be a global ...
(Date:8/20/2014)... News) -- Leaving the car at home and getting to ... your health, a new study indicates. Researchers looked at ... 76 percent of men and 72 percent of women drove ... women used public transit, and 14 percent of men and ... drove to work weighed more and had higher levels of ...
Breaking Medicine News(10 mins):Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Little Green Pouch Launches New Product to Help Health-conscious Parents Reduce Babies’ Eco-footprint 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Want to Stay Slim? Leave the Car at Home 2
... People with mesothelioma — a form of cancer associated with ... with a combination// of two cancer drugs, a large multicenter ... cancer that occurs in the lining of the lungs, heart ... no known cure. ,In the study, patients receiving ...
... in Vitamin D3 levels control the body’s innate immune ... ,Richard L. Gallo, M.D., Ph.D., professor of medicine ... Dermatology section of the Veterans Affairs San Diego Healthcare ... the body’s vitamin D3 and infectious disease have emerged ...
... now. Hitherto, there used to be unsubstantiated suggestions to ... effect now from authoritive sources: a study by university ... postdoctoral researcher in the Berkeley Olfactory Research Program, who ... some insects, human secretions too influence the physiology of ...
... spread awareness of health issues like stroke// , prostate cancer ... as vital as any doctor, drug or diagnostic test. ... the American Stroke Association's International Stroke Conference suggests beauty shops ... strokes. ,In the study, researchers gave lessons on ...
... more stress than boys, especially in their interpersonal relationships//, ... by mid puberty (age 13 or so) more girls ... by the online edition of Daily Mail, says girls ... than boys. ,Benjamin L. Hankin, assistant professor ...
... Two scientists have come out strongly against the NHS's ... in the age group 25 to 29, leaving// out women ... Consultant cytopathologists Amanda Herbert, from Guy's and St. Thomas' NHS ... Hallamshire Hospital in Sheffield, girls have started having sex at ...
Cached Medicine News:Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3Health News:Vitamin D3 Protects Skin from Harmful Microbes 2Health News:The Secretions Influence Opposite Sex 2Health News:Beauticians and Barbers can Do More Than Their Services 2Health News:Extend Cervical Smears to Younger Women, Insist Specialists 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: